Literature DB >> 24901259

Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000.

Philippe Morlat1, Caroline Roussillon, Sandrine Henard, Dominique Salmon, Fabrice Bonnet, Patrice Cacoub, Aurore Georget, Albertine Aouba, Eric Rosenthal, Thierry May, Marie Chauveau, Bilghissa Diallo, Dominique Costagliola, Geneviève Chene.   

Abstract

OBJECTIVE: The Mortalité 2010 survey aimed at describing the causes of death among HIV-infected patients in France in 2010 and their evolution since 2000. DESIGN AND METHODS: A national sample of clinical sites, providing HIV care and treatment, notified and documented deaths using a standardized questionnaire.
RESULTS: The 90 participating wards notified 728 deaths. Median age at death was 50 years (interquartile range 45-58) and 75% were men. The main underlying causes of death were AIDS-related (25% in 2010 vs. 36% in 2005 and 47% in 2000), non-AIDS non-viral hepatitis-related malignancy (22 vs. 17 and 11%), liver-related (11 vs. 15 and 13%), cardiovascular diseases (10 vs. 8 and 7%) and non-AIDS-related infections (9 vs. 4 and 7%). Malignancies (AIDS and non-AIDS-related) accounted for a third of all causes of death. AIDS accounted for 33% of all causes of death among patients mono-infected with HIV vs. only 13% among those co-infected with hepatitis B virus or hepatitis C virus.
CONCLUSION: In 2010, 25% of the causes of death among HIV-infected patients remained AIDS-related. Improved screening and earlier HIV treatment should lead to a smaller proportion of deaths due to AIDS. The majority of patients died of various causes, whereas their HIV infection was well controlled under treatment. Improving case management of HIV-infected patients should include a multidisciplinary approach (prevention, screening, treatment), especially in oncology. Smoking cessation should be a priority goal.

Entities:  

Mesh:

Year:  2014        PMID: 24901259     DOI: 10.1097/QAD.0000000000000222

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  76 in total

1.  Cancer and HIV infection in referral hospitals from four West African countries.

Authors:  Antoine Jaquet; Michael Odutola; Didier K Ekouevi; Aristophane Tanon; Emmanuel Oga; Jocelyn Akakpo; Manhattan Charurat; Marcel D Zannou; Serge P Eholie; Annie J Sasco; Emmanuel Bissagnene; Clement Adebamowo; Francois Dabis
Journal:  Cancer Epidemiol       Date:  2015-09-12       Impact factor: 2.984

2.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

3.  Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study.

Authors:  Aaron P Thrift; Jennifer R Kramer; Christine M Hartman; Kathryn Royse; Peter Richardson; Yongquan Dong; Suchismita Raychaudhury; Roxanne Desiderio; Dina Sanchez; Sharmila Anandasabapathy; Donna L White; Elizabeth Y Chiao
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

Review 4.  Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation.

Authors:  Avanthi Raghavan; Dodie E Rimmelin; Kathleen V Fitch; Markella V Zanni
Journal:  Curr HIV/AIDS Rep       Date:  2017-12       Impact factor: 5.071

Review 5.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

Review 6.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

Review 7.  Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.

Authors:  Cristina Brickman; Joel M Palefsky
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

8.  Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.

Authors:  Zobair M Younossi; Maria Stepanova; Mark Sulkowski; Susanna Naggie; Massimo Puoti; Chloe Orkin; Sharon L Hunt
Journal:  J Infect Dis       Date:  2015-01-12       Impact factor: 5.226

Review 9.  The role of viral co-infection in HIV-associated non-AIDS-related cancers.

Authors:  David J Riedel; Lydia S Tang; Anne F Rositch
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

Review 10.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.